Cyclopharm Limited (ASX: CYC)

Cyclopharm Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27.56	11.73	20.3	29.25	1.87	12.66
Cash & Short-Term Investments	28.89	11.73	20.3	29.25	1.87	12.66
Cash Growth	59.82%	-42.22%	-30.61%	1460.56%	-85.20%	116.23%
Accounts Receivable	4.79	5.74	5.25	4.66	5.35	3.57
Other Receivables	2.21	2.15	2.46	3.44	3.72	0.64
Receivables	7	7.9	7.71	8.1	9.07	4.21
Inventory	10.39	10.12	8.29	5.51	4.74	2.5
Other Current Assets	0.81	0.45	0.57	0.39	0.3	0.25
Total Current Assets	47.09	30.2	36.87	43.25	15.98	19.61
Property, Plant & Equipment	10.4	9.19	6.6	6.25	5.81	6.28
Goodwill	-	0.9	0.87	0.87	0.87	0.87
Other Intangible Assets	5.76	4.04	3.78	3.77	3.64	3.49
Long-Term Deferred Tax Assets	0.83	0.76	0.64	0.82	1.19	1.49
Long-Term Deferred Charges	-	0.79	0.79	0.79	0.79	0.79
Other Long-Term Assets	-	0.03	-	-	-	-
Total Assets	64.09	45.91	49.54	55.74	28.28	32.53
Accounts Payable	3.8	3.15	4.4	2.17	3.3	1.41
Accrued Expenses	1.75	1.48	1.13	1.23	1.02	0.65
Current Portion of Leases	0.92	0.21	0.21	0.18	0.15	0.17
Current Income Taxes Payable	0.07	0.04	0.09	0.1	0.11	0.02
Other Current Liabilities	4.21	3.79	2.1	3.73	1.1	1.22
Total Current Liabilities	10.74	8.67	7.94	7.42	5.68	3.48
Long-Term Leases	4.65	4.01	4.12	4.33	4.56	4.75
Long-Term Unearned Revenue	0.9	0.9	0.9	0.9	0.89	0.79
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.28
Other Long-Term Liabilities	0.24	0.07	0.05	0.03	0.02	0.02
Total Liabilities	16.54	13.65	13.01	12.67	11.16	9.32
Common Stock	92.42	69.11	68.75	68.31	36.97	36.91
Retained Earnings	-42.17	-34.66	-29.07	-21.58	-15.66	-8.86
Comprehensive Income & Other	-2.71	-2.2	-3.14	-3.66	-4.19	-4.84
Shareholders' Equity	47.55	32.26	36.54	43.07	17.12	23.2
Total Liabilities & Equity	64.09	45.91	49.54	55.74	28.28	32.53
Total Debt	5.57	4.23	4.33	4.51	4.71	4.92
Net Cash (Debt)	23.32	7.5	15.96	24.74	-2.83	7.74
Net Cash Growth	68.50%	-53.03%	-35.47%	-	-	34.94%
Net Cash Per Share	0.25	0.08	0.17	0.28	-0.04	0.11
Filing Date Shares Outstanding	111.14	94.1	93.05	93.37	93.37	78.24
Total Common Shares Outstanding	111.14	94.1	93.05	93.37	80.27	78.24
Working Capital	36.35	21.53	28.93	35.83	10.29	16.13
Book Value Per Share	0.43	0.34	0.39	0.46	0.21	0.30
Tangible Book Value	41.79	27.31	31.89	38.43	12.61	18.85
Tangible Book Value Per Share	0.38	0.29	0.34	0.41	0.16	0.24
Land	-	1.4	0.5	0.55	0.51	0.51
Machinery	-	5.76	4.85	4.65	4.3	4.06
Construction In Progress	-	-	0.1	0.1	0.09	0.07
Leasehold Improvements	-	4.26	3.25	2.72	2.26	2.21

Source: S&P Capital IQ. Standard template. Financial Sources.